Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/1073274817729070 http://scihub22266oqcxt.onion/10.1177/1073274817729070 C5937239!5937239!28975823     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cancer+Control 2017 ; 24 (5): ä Nephropedia Template TP {{tp|p=28975823|t=2017. Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue |pdf=|usr=}}{{28975823}} gab.com Text Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue JO: Cancer Control http://www.kidney.de/pget.php?&tw=1&pmid=28975823 #FOAvip Methylene blue is a widely used treatment for ifosfamide neurotoxicity. We present a case of severe encephalopathy complicating ifosfamide-based therapy for recurrent retroperitoneal leiomyosarcoma. After treatment with methylene blue, the patient experienced clinical decompensation and was diagnosed with serotonin syndrome based on a constellation of clinical findings. Withdrawal of methylene blue and other serotonergic medications led to clinical stabilization and ultimately neurological recovery. Our case highlights the challenge of diagnosing serotonin syndrome in the face of preexisting ifosfamide neurotoxicity, as there is significant clinical overlap between these 2 syndromes. Practitioners must remain vigilant of this potential life-threatening complication in this vulnerable population. Twit Text FOAVip Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue ????Cancer Control http://www.kidney.de/pget.php?&tw=1&pmid=28975823 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28975823 #FOAvip English Wikipedia <ref>{{Cite pmid|28975823}}</ref> Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue #MMPMID28975823 Snyder M; Gangadhara S; Brohl AS; Ludlow S; Nanjappa S Cancer Control 2017[Dec]; 24 (5): ä PMID28975823show ga Methylene blue is a widely used treatment for ifosfamide neurotoxicity. We present a case of severe encephalopathy complicating ifosfamide-based therapy for recurrent retroperitoneal leiomyosarcoma. After treatment with methylene blue, the patient experienced clinical decompensation and was diagnosed with serotonin syndrome based on a constellation of clinical findings. Withdrawal of methylene blue and other serotonergic medications led to clinical stabilization and ultimately neurological recovery. Our case highlights the challenge of diagnosing serotonin syndrome in the face of preexisting ifosfamide neurotoxicity, as there is significant clinical overlap between these 2 syndromes. Practitioners must remain vigilant of this potential life-threatening complication in this vulnerable population. äSerotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity (epmc).pdf DeepDyve Pubget Overpricing